Biocon Ltd. Approves Fund Raising of Up to INR 4,500 Crores and Increases Authorised Share Capital

Biocon Ltd. announced the outcome of its Board Meeting held on April 23, 2025. The Board approved the fundraising of up to INR 4,500 crores through various methods, including QIP, rights issue, preferential allotment, or private placement. The company will increase its authorized share capital from INR 625 crores to INR 700 crores and amend its Memorandum of Association accordingly. The approval of shareholders and necessary regulatory/statutory approvals are awaited. The company will communicate the Postal Ballot Notice to shareholders in due course.